{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:57:10Z","timestamp":1788645430617,"version":"build-2803163510"},"reference-count":44,"publisher":"BMJ","issue":"4","funder":[{"name":"National Institute for Health Research (NIHR)\/Wellcome Trust Imperial Clinical Research Facility"},{"name":"British Heart Foundation programme grant"},{"name":"British Heart Foundation Intermediate Basic Science Research Fellowship"},{"name":"Imperial College Junior Research Fellowship"},{"name":"European Respiratory Society Research Fellowship"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2018,11,12]]},"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Aberrant lipoprotein metabolism has been implicated in experimental pulmonary hypertension, but the relevance to patients with pulmonary arterial hypertension (PAH) is inconclusive.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the relationship between circulating lipoprotein subclasses and survival in patients with PAH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using nuclear magnetic resonance spectroscopy, 105 discrete lipoproteins were measured in plasma samples from two cohorts of patients with idiopathic or heritable PAH. Data from 1124 plasma proteins were used to identify proteins linked to lipoprotein subclasses. The physical presence of proteins was confirmed in plasma lipoprotein subfractions separated by ultracentrifugation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Plasma levels of three lipoproteins from the small high-density lipoprotein (HDL) subclass, termed HDL-4, were inversely related to survival in both the discovery (n=127) and validation (n=77) cohorts, independent of exercise capacity, comorbidities, treatment, N-terminal probrain natriuretic peptide, C reactive protein and the principal lipoprotein classes. The small HDL subclass rich in apolipoprotein A-2 content (HDL-4-Apo A-2) exhibited the most significant association with survival. None of the other lipoprotein classes, including principal lipoprotein classes HDL and low-density lipoprotein cholesterol, were prognostic. Three out of nine proteins identified to associate with HDL-4-Apo A-2 are involved in the regulation of fibrinolysis, namely, the plasmin regulator, alpha-2-antiplasmin, and two major components of the kallikrein\u2013kinin pathway (coagulation factor XI and prekallikrein), and their physical presence in the HDL-4 subfraction was confirmed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Reduced plasma levels of small HDL particles transporting fibrinolytic proteins are associated with poor outcomes in patients with idiopathic and heritable PAH.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2018-212144","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T22:15:32Z","timestamp":1543270532000},"page":"380-389","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension"],"prefix":"10.1136","volume":"74","author":[{"given":"Lars","family":"Harbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavandeep","family":"Ghataorhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2822-210X","authenticated-orcid":false,"given":"Luke S G","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Simon R","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy K","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"2024092104351167000_74.4.380.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.032"},{"key":"2024092104351167000_74.4.380.2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60658"},{"key":"2024092104351167000_74.4.380.3","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22904"},{"key":"2024092104351167000_74.4.380.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024602"},{"key":"2024092104351167000_74.4.380.5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehx566","article-title":"Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials","volume":"39","author":"Koskinas","year":"2018","journal-title":"Eur Heart J"},{"key":"2024092104351167000_74.4.380.6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.hlc.2016.08.005","article-title":"Efficacy and safety of statins for pulmonary hypertension: a meta-analysis of randomised controlled trials","volume":"26","author":"Zhang","year":"2017","journal-title":"Heart Lung Circ"},{"key":"2024092104351167000_74.4.380.7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/687304","article-title":"A systematic review and meta-analysis of trials using statins in pulmonary arterial hypertension","volume":"6","author":"Anand","year":"2016","journal-title":"Pulm Circ"},{"key":"2024092104351167000_74.4.380.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2011.05.013"},{"key":"2024092104351167000_74.4.380.9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32503"},{"key":"2024092104351167000_74.4.380.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.007405"},{"key":"2024092104351167000_74.4.380.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0007OC"},{"key":"2024092104351167000_74.4.380.12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjcard.2016.04.028","article-title":"Usefulness of high-density lipoprotein cholesterol to predict survival in pulmonary arterial hypertension","volume":"118","author":"Larsen","year":"2016","journal-title":"Am J Cardiol"},{"key":"2024092104351167000_74.4.380.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.03.042"},{"key":"2024092104351167000_74.4.380.14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1164\/ajrccm.186.1.107","article-title":"Plasma levels of high-density lipoprotein cholesterol are not associated with survival in pulmonary arterial hypertension","volume":"186","author":"Cracowski","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2024092104351167000_74.4.380.15","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.155333"},{"key":"2024092104351167000_74.4.380.16","doi-asserted-by":"publisher","DOI":"10.1038\/nature11708"},{"key":"2024092104351167000_74.4.380.17","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1021\/acs.analchem.7b01329","article-title":"Toward reliable lipoprotein particle predictions from nmr spectra of human blood: an interlaboratory ring test","volume":"89","author":"Monsonis Centelles","year":"2017","journal-title":"Anal Chem"},{"key":"2024092104351167000_74.4.380.18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26206"},{"key":"2024092104351167000_74.4.380.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.108753"},{"key":"2024092104351167000_74.4.380.20","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.186031"},{"key":"2024092104351167000_74.4.380.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2024092104351167000_74.4.380.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.05.047"},{"key":"2024092104351167000_74.4.380.23","doi-asserted-by":"publisher","DOI":"10.1021\/ac5025039"},{"key":"2024092104351167000_74.4.380.24","doi-asserted-by":"publisher","DOI":"10.1021\/ac402571z"},{"key":"2024092104351167000_74.4.380.25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(17)30161-3","article-title":"Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study","volume":"5","author":"Rhodes","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024092104351167000_74.4.380.26","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600094-JLR200"},{"key":"2024092104351167000_74.4.380.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI103182"},{"key":"2024092104351167000_74.4.380.28","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.092"},{"key":"2024092104351167000_74.4.380.29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bth445"},{"key":"2024092104351167000_74.4.380.30","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303"},{"key":"2024092104351167000_74.4.380.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2014.04.010"},{"key":"2024092104351167000_74.4.380.32","doi-asserted-by":"publisher","DOI":"10.1038\/89986"},{"key":"2024092104351167000_74.4.380.33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2024092104351167000_74.4.380.34","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R039297"},{"key":"2024092104351167000_74.4.380.35","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.145672"},{"key":"2024092104351167000_74.4.380.36","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(85)90116-1"},{"key":"2024092104351167000_74.4.380.37","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13235"},{"key":"2024092104351167000_74.4.380.38","doi-asserted-by":"crossref","first-page":"52995","DOI":"10.18632\/oncotarget.18031","article-title":"Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension","volume":"8","author":"Hautefort","year":"2017","journal-title":"Oncotarget"},{"key":"2024092104351167000_74.4.380.39","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu141"},{"key":"2024092104351167000_74.4.380.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706628"},{"key":"2024092104351167000_74.4.380.41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1649"},{"key":"2024092104351167000_74.4.380.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00149-1"},{"key":"2024092104351167000_74.4.380.43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1165\/rcmb.2016-0060TR","article-title":"Emerging roles of apolipoprotein e and apolipoprotein a-i in the pathogenesis and treatment of lung disease","volume":"55","author":"Yao","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024092104351167000_74.4.380.44","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw152"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2018-212144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T11:36:41Z","timestamp":1726918601000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2018-212144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,3,14]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1136\/thoraxjnl-2018-212144"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212144","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]}}}